Narwhal Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.5M Sell
20,444
-1,040
-5% -$1.06M 1.69% 13
2026
Q1
$19.8M Buy
21,484
+550
+3% +$558K 1.46% 16
2025
Q4
$22.5M Sell
20,934
-2,288
-10% -$2.19M 1.63% 12
2025
Q3
$17.7M Sell
23,222
-2,154
-8% -$1.6M 1.31% 19
2025
Q2
$19.8M Buy
25,376
+3,845
+18% +$2.99M 1.59% 14
2025
Q1
$17.8M Sell
21,531
-925
-4% -$770K 1.58% 15
2024
Q4
$17.3M Buy
22,456
+1,053
+5% +$872K 1.53% 15
2024
Q3
$19M Buy
21,403
+3,407
+19% +$3.06M 1.71% 13
2024
Q2
$16.3M Buy
17,996
+1,821
+11% +$1.46M 1.54% 17
2024
Q1
$12.6M Sell
16,175
-2,764
-15% -$1.97M 1.23% 21
2023
Q4
$11M Sell
18,939
-632
-3% -$369K 1.21% 21
2023
Q3
$10.5M Sell
19,571
-2,500
-11% -$1.29M 1.28% 21
2023
Q2
$10.4M Sell
22,071
-3,935
-15% -$1.65M 1.22% 23
2023
Q1
$8.93M Buy
26,006
+5,675
+28% +$1.91M 1.12% 29
2022
Q4
$7.44M Buy
20,331
+3,133
+18% +$1.11M 0.99% 34
2022
Q3
$5.56M Buy
17,198
+16,340
+1,904% +$5.18M 0.81% 39
2022
Q2
$278K Hold
858
0.04% 131
2022
Q1
$246K Sell
858
-230
-21% -$59.2K 0.03% 133
2021
Q4
$301K Sell
1,088
-154
-12% -$39K 0.03% 129
2021
Q3
$287K Hold
1,242
0.04% 131
2021
Q2
$285K Buy
+1,242
New +$249K 0.04% 133
2014
Q1
Sell
-10,500
Closed -$535K 142
2013
Q4
$535K Sell
10,500
-1,000
-9% -$50.1K 0.22% 113
2013
Q3
$579K Buy
11,500
+1,000
+10% +$52.4K 0.28% 107
2013
Q2
$516K Buy
+10,500
New +$571K 0.25% 108

Other funds holding LLY

Narwhal Capital Management's LLY Position: Q2 2026 in Review

Narwhal Capital Management reduced its Eli Lilly (LLY) stake by 4.8% in Q2 2026, selling an estimated $1.06M and leaving 20,444 shares worth $24.5M. The position accounts for 1.69% of the portfolio, ranked #13.

Narwhal Capital Management first reported a position in LLY in Q2 2013 and has held it in 24 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Narwhal Capital Management held 20,444 shares of Eli Lilly worth $24.5M as of Q2 2026.
  • Narwhal Capital Management sold 1,040 Eli Lilly shares in Q2 2026, an estimated $1.06M.
  • Eli Lilly made up 1.69% of Narwhal Capital Management's portfolio in Q2 2026, its #13 holding.
  • Narwhal Capital Management first reported a position in Eli Lilly in Q2 2013 and has held it in 24 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Narwhal Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.